Though hugely promising, these rapid advances can be difficult to adapt to in the short term. They also raise ethical and legal questions around issues such as data privacy and consent as well as health equity.
To understand the industry’s perspective on these trends, as well as their views on a range of other opportunities, risks and challenges, WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, asked more than 600 industry leaders and decision makers for their views.
Please find the full Global Life Sciences Risk Outlook 2023 report and executive summary attached.
The full report, alongside a detailed analysis, can be downloaded from the WTW website: https://www.wtwco.com/en-GB/Insights/2022/12/global-life-sciences-risk-outlook-2023
Scan here to download the app